I am a pharmaceutical business development professional with techno-commercial experience in:In / Out Licensing ActivitiesNCE Drug Target EvaluationAcademic Research CollaborationsPortfolio Prioritization & Optimisation New Product IdeationSales Forecasting Financial Modeling (DCF / NPV Analysis) NCE/NDDS R&D Product StrategyUS/EU Market Access StudiesCompetition AnlysesTherapy Gap AnalysisKOL Identification & LiasoningM&AsI develop & deliver techno-commercial analyses that address key business questions, generate business insights and provide techno-commercial recommendations to the management team to help them formulate appropriate business strategy. I enjoy identifying the gaps in the existing therapy/dosage regime and proposing acceptable dosage forms and strengths which adds value to the existing drug product.I enjoy assessing unmet medical needs and identifying NCE/NBE and 505b2 product opportunities w.r.t. new drug targets (first-in-class / best-in-class), potential changes in existing dosage regime, targeted patient population, dosage form, route of administration that can help address such medical needs. I love conducting SWOT analyses of the competition that includes marketed drugs as well as pipeline assets. I enjoy devoting time in preparing business cases and formulating sales forecasts/NPV models to help the management take informed decisions. I have travelled to Israel to meet principal investigators/researchers at the leading Israeli Universities to explore potential in-licensing opportunities in novel drug delivery systems and new drug discovery. Visited Japan for on-site R&D due diligence of a Japanese M&A target and to explore out-licensing of SPARC products for the Japanese market. Travelled to the US to attend business and scientific conferences to meet potential collaborators and identify in-licensing opportunities.